Gary Wilkinson
4PUBLICATIONS
36CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jun 14, 2025
Phase Ib Basket Expansion Trial and Alternative-Schedule Dose-Escalation Study of ATR Inhibitor Elimusertib in Advanced Solid Tumors with DNA Damage Response Defects.Timothy A Yap, David S P Tan, Anastasios Stathis
|Oct 22, 2024
First-in-Human Dose-Escalation Study of the First-in-Class PDE3A-SLFN12 Complex Inducer BAY 2666605 in Patients with Advanced Solid Tumors Coexpressing SLFN12 and PDE3A.Kyriakos P Papadopoulos, Meredith McKean, Silvia Goldoni
|Sep 29, 2020
First-in-Human Trial of the Oral Ataxia Telangiectasia and RAD3-Related (ATR) Inhibitor BAY 1895344 in Patients with Advanced Solid Tumors.Timothy A Yap, David S P Tan, Angelika Terbuch
|Dec 15, 2019
Phase 1 Dose Escalation Study of the Allosteric AKT Inhibitor BAY 1125976 in Advanced Solid Cancer-Lack of Association between Activating AKT Mutation and AKT Inhibition-Derived Efficacy.Andreas Schneeweiss, Dagmar Hess, Markus Joerger
Pageof 1
Frequent Collaborators
3 joint publications
Timothy A Yap
2 joint publications
Markus Joerger
2 joint publications
David S P Tan
2 joint publications
Ruth Plummer
1 joint publications
Andrea Varga
1 joint publications
Oliver Boix
1 joint publications
Matthias Ocker
1 joint publications
Christina Guo
1 joint publications
Valerie Heong
1 joint publications
Yvette Drew
